Gatherings in Esophagology: Innovations and Future Directions in the Diagnosis and Management of Reflux Disease.
Conference ProceedingsНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cable Jennifer, Giuli Robert, Fox Mark R, Rosen Rachel L, Valdovinos-García Luis R, Siboni Stefano, Clarke John O, Johnston Nikki, Samuels Tina L, Scarpignato Carmelo, Stein Ellen M, Fass Ronnie, Remes-Troche José María, Khan Abraham, Rahman Afrin K, Lynch Kristle, Jodorkovsky Daniela, Vela Marcelo F, Vandenberg Alexandra, Kuo Braden, Ergun Pelin, Jirapinyo Pichamol, Asti Emanuele, Tolone Salvatore, Sheu Eric G, Salvador Renato, Sozzi Marco, Husain Inna A, Wu Justin C, Hobson Anthony, Sharma Nirmal S, Lo Wai-Kit, Duncan Daniel R, Gyawali C Prakash, Chan Walter W, Sifrim Daniel, Savarino Edoardo, de Bortoli Nicola, Rogers Benjamin D
Аннотация
Recent advances in the diagnosis and management of reflux disease were the central focus of the inaugural Gatherings in Esophagology (GiE), which convened experts across gastroenterology, surgery, otolaryngology, pulmonology, and basic research. The sessions highlighted innovations in reflux monitoring-including high-resolution manometry, wireless pH monitoring, and novel salivary biomarkers-while critically evaluating their diagnostic accuracy and clinical utility. Presentations explored the limitations of traditional proton-pump inhibitor therapy, the emergence of potassium-competitive acid blockers as a new class of acid suppressants, and the evolving role of adjunctive treatments such as mucosal protectants, reflux reducers, and neuromodulators for refractory symptoms. The discourse extended to advanced interventional procedures, including transoral incisionless fundoplication, magnetic sphincter augmentation, and the RefluxStop device, with discussion of patient selection, efficacy, and complication management. Discussants emphasized the pathophysiology and management of extraesophageal manifestations of reflux, the interplay between reflux and pulmonary disease, and the diagnostic challenges in pediatric populations. The meeting also addressed the integration of behavioral therapies, the role of the microbiome, and the application of artificial intelligence in reflux diagnostics. Collectively, these insights underscore a shift toward precision medicine in reflux disease, emphasizing individualized diagnostic strategies and tailored therapeutic approaches to improve patient outcomes.